scAAV1.tMCK.NTF3 / Sarepta Therap 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
  • ||||||||||  scAAV1.tMCK.NTF3 / Sarepta Therap
    Trial completion date, Trial primary completion date:  Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A (clinicaltrials.gov) -  May 1, 2024   
    P1/2,  N=3, Suspended, 
    Trial completion date: Jul 2024 --> Apr 2030 | Trial primary completion date: Mar 2024 --> Apr 2028
  • ||||||||||  scAAV1.tMCK.NTF3 / Sarepta Therap
    Trial completion date, Trial primary completion date:  Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A (clinicaltrials.gov) -  Mar 14, 2023   
    P1/2,  N=3, Suspended, 
    Trial completion date: Jul 2024 --> Apr 2030 | Trial primary completion date: Mar 2024 --> Apr 2028 Trial completion date: Jul 2023 --> Jul 2024 | Trial primary completion date: Mar 2023 --> Mar 2024
  • ||||||||||  scAAV1.tMCK.NTF3 / Sarepta Therap
    Trial suspension:  Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A (clinicaltrials.gov) -  Jun 24, 2021   
    P1/2,  N=3, Suspended, 
    Trial completion date: Jul 2023 --> Jul 2024 | Trial primary completion date: Mar 2023 --> Mar 2024 Recruiting --> Suspended
  • ||||||||||  scAAV1.tMCK.NTF3 / Sarepta Therap
    Enrollment open:  Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A (clinicaltrials.gov) -  Nov 19, 2020   
    P1/2,  N=3, Recruiting, 
    Recruiting --> Suspended Not yet recruiting --> Recruiting
  • ||||||||||  scAAV1.tMCK.NTF3 / Sarepta Therap
    Trial completion date, Trial primary completion date:  Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A (clinicaltrials.gov) -  Feb 19, 2020   
    P1/2,  N=9, Not yet recruiting, 
    Not yet recruiting --> Recruiting Trial completion date: Apr 2020 --> Jul 2023 | Trial primary completion date: Apr 2020 --> Mar 2023
  • ||||||||||  scAAV1.tMCK.NTF3 / Sarepta Therap
    Trial initiation date:  Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A (clinicaltrials.gov) -  Feb 20, 2019   
    P1/2,  N=9, Recruiting, 
    Trial completion date: Apr 2020 --> Jul 2023 | Trial primary completion date: Apr 2020 --> Mar 2023 Initiation date: Jan 2019 --> Jul 2019
  • ||||||||||  scAAV1.tMCK.NTF3 / Sarepta Therap
    Trial initiation date:  Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A (clinicaltrials.gov) -  Dec 5, 2018   
    P1/2,  N=9, Recruiting, 
    Initiation date: Jan 2019 --> Jul 2019 Initiation date: Oct 2018 --> Jan 2019
  • ||||||||||  scAAV1.tMCK.NTF3 / Sarepta Therap
    Trial initiation date:  Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A (clinicaltrials.gov) -  Jul 17, 2018   
    P1/2,  N=9, Recruiting, 
    Initiation date: Oct 2018 --> Jan 2019 Initiation date: Jun 2018 --> Oct 2018